Molecular subtyping improves prognostication of Stage 2 colorectal cancer.

Rachel V PurcellSebastian SchmeierYee Chen LauJohn F PearsonFrancis A Frizelle

Published in: BMC cancer (2019)

Although stratification using CMS does not outperform TNM staging as a prognostic indicator, gene-expression based subtyping shows promise for improved prognostication in stage 2 CRC.

Keyphrases

gene expression
dna methylation
lymph node
pet ct
single molecule
machine learning